ADDUS HOMECARE CORP (ADUS)
Sector: Health Care
2026 Annual Meeting Analysis
ADDUS HOMECARE CORP · Meeting: June 10, 2026
Directors FOR
0
Directors AGAINST
2
Say on Pay
AGAINST
Auditor
FOR
Director Elections
Election of Class II Directors
Against Analysis
Mr. Earley has served since 2014, giving him full overlap with the 3-year underperformance period; ADUS stock fell 13.6% over three years while the company's own compensation peer group gained 34.4% on average, a gap of 48 percentage points that far exceeds the 20-point trigger for companies with negative absolute returns — however, the 5-year record shows ADUS at -12.0% versus the peer median of -12.8%, a gap of only +0.8pp that does not exceed the 20pp threshold, so the policy's 5-year mitigant applies and the vote is downgraded from AGAINST to FOR, indicating the recent 3-year trough appears to be a short-term deviation from an otherwise adequate longer-term track record.
Ms. Hill-Milbourne joined in January 2021, giving her meaningful overlap with the 3-year underperformance period; the same 48-percentage-point gap versus peer median triggers a No vote — however, applying the 5-year mitigant, the 5-year gap of +0.8pp does not exceed the 20pp threshold, so the vote is downgraded to FOR, reflecting that the underperformance appears recent rather than sustained across her full tenure.
For Analysis
Both Class II nominees (Earley and Hill-Milbourne) initially trigger an AGAINST vote due to severe 3-year stock underperformance — ADUS declined 13.6% while its compensation peer group gained 34.4%, a 48-percentage-point gap far exceeding the 20pp policy threshold for companies with negative absolute returns. However, the 5-year mitigant applies to both directors: over five years, ADUS returned -12.0% versus the peer median of -12.8%, a gap of only +0.8pp that does not breach the 20pp threshold. Per policy, when the 5-year relative performance is adequate, the vote is downgraded from AGAINST to FOR, indicating the recent underperformance is a short-term development within an otherwise acceptable long-term track record. Both directors receive a FOR vote.
Say on Pay
✗ AGAINSTCEO
R. Dirk Allison
Total Comp
$12,190,449
Prior Support
overwhelming majority%
CEO R. Dirk Allison received total compensation of $12,190,449 in 2025, driven primarily by $9,767,870 in stock awards — including a special retention grant of 63,500 shares valued at approximately $6 million on top of regular performance equity — which is substantially above the expected range for a CEO at a $1.8 billion healthcare services company and triggers the individual CEO threshold under the policy. Beyond the pay level concern, the pay-for-performance alignment check fails: Addus shareholders lost 13.6% over three years while the company's own peer group gained an average of 34.4%, yet above-benchmark variable pay was awarded, indicating the incentive structure is not working as intended. Additionally, the company's equity grants vest based solely on time after meeting an Adjusted EBITDA threshold — with no multi-year stock performance condition — meaning awards function more like deferred salary than true performance pay, which the policy flags as a concern about pay quality.
Auditor Ratification
✓ FORAuditor
PricewaterhouseCoopers LLP
Tenure
N/A
Audit Fees
N/A
Non-Audit Fees
N/A
The proxy filing does not include an auditor fee table with specific audit and non-audit fee amounts, and auditor tenure is not explicitly disclosed in the provided filing text; with no fee ratio trigger calculable and no confirmed tenure of 25 or more years, no policy threshold fires, and PricewaterhouseCoopers is a Big 4 firm fully appropriate for a $1.8 billion company, so the default FOR vote applies.
Overall Assessment
The 2026 Addus HomeCare annual meeting presents three standard proposals: both Class II director nominees initially trigger the TSR underperformance threshold due to a severe 48-percentage-point lag versus peers over three years, but the 5-year mitigant applies and both receive FOR votes reflecting adequate longer-term performance; the Say on Pay vote receives an AGAINST recommendation due to above-benchmark CEO compensation driven by a large special retention grant combined with significant stock underperformance versus peers, and an equity program that lacks meaningful long-term stock price conditions. The auditor ratification receives a FOR vote as no fee or tenure data was available to trigger a policy threshold and PwC is an appropriate Big 4 auditor for the company's size.
Compensation Peer Group
13 companies disclosed in 2026 proxy filing